Connection

Jonathan Halford to Natalizumab

Back to Details
This is a "connection" page, showing publications Jonathan Halford has written about Natalizumab.
Jonathan Halford
Connection Strength
0.047
Natalizumab
  1. Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study. Neurology. 2021 11 02; 97(18):e1757-e1767.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.